You are here

patents

Merck, Viatris agree to settle patent feud surrounding diabetes drugs

Endpoints

Mon, 03/20/23 - 04:30 pm

Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim

Fierce Pharma

Fri, 03/3/23 - 11:56 am

Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri

Fierce Pharma

Wed, 03/1/23 - 07:08 pm

multiple sclerosis

Warren urges US patent office to scrutinize Merck's efforts with Keytruda

Fierce Pharma

Thu, 02/23/23 - 04:25 pm

Elizabeth Warren

Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’

BioPharma Dive

Tue, 02/21/23 - 11:05 am

Bristol Myers Squibb

Novartis loses $940M arbitration case against Mitsubishi Chemical over Gilenya royalties

Fierce Pharma

Mon, 02/20/23 - 12:42 pm

Mitsubishi Chemical

multiple sclerosis

Daiichi Sankyo gets US patent office to restart review of Seagen patent

Endpoints

Mon, 02/20/23 - 12:40 pm

Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case

Fierce Pharma

Wed, 02/15/23 - 10:52 am

US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case

Endpoints

Mon, 02/13/23 - 10:12 pm

The end of the Humira era

EP Vantage

Mon, 01/30/23 - 10:46 am

In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'

Endpoints

Thu, 01/26/23 - 05:05 pm

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo

Fierce Pharma

Tue, 01/24/23 - 06:31 pm

Bristol Myers Squibb

Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent

Endpoints

Tue, 01/24/23 - 06:18 pm

multiple sclerosis

Masimo Takes a Bite Out of Apple

Medical Devices and Diagnostics Industry

Wed, 01/11/23 - 10:50 am

Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Fierce Pharma

Thu, 01/5/23 - 05:00 pm

Astellas loses bid to block Lexiscan generics in US

Pharmaphorum

Wed, 01/4/23 - 05:15 pm

Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support

Endpoints

Tue, 01/3/23 - 10:24 pm

AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort

Fierce Pharma

Fri, 12/16/22 - 11:08 am

Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book

Endpoints

Thu, 12/15/22 - 11:04 pm

Court swats down Vanda's patent suit against Teva and Apotex, clearing the way for Hetlioz generics

Fierce Pharma

Wed, 12/14/22 - 07:37 pm

Vanda Pharmaceuticals

Teva Pharmaceutical

Pages